Insulin-like growth factors (IGF-I and -II): New actors in the development of non-alcoholic fatty liver disease

Research output: Contribution to journalArticlepeer-review

Abstract

Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease worldwide, affecting 20-30% of adults and 3-10% of children in Western countries. The pathogenesis of NAFLD is considered to be multifactorial and factors such as insulin resistance, intrahepatic fat accumulation, oxidative stress, mitochondrial alterations, and stellate cell activation appear to substantially contribute to the development and progression of the disease. In this Editorial, we highlight some evidence suggesting a close link between NAFLD and growth hormone (GH)-IGF (insulin-like growth factor) axis.

Original languageEnglish
Pages (from-to)193-195
Number of pages3
JournalExpert Review of Endocrinology and Metabolism
Volume9
Issue number3
DOIs
Publication statusPublished - 2014

Keywords

  • Children
  • Cytokines
  • Fatty liver
  • Gh therapy
  • IGFs

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Insulin-like growth factors (IGF-I and -II): New actors in the development of non-alcoholic fatty liver disease'. Together they form a unique fingerprint.

Cite this